<DOC>
	<DOCNO>NCT00085891</DOCNO>
	<brief_summary>The purpose study demonstrate superior efficacy sustain release quetiapine compare placebo patient schizophrenia receive treatment 6 week .</brief_summary>
	<brief_title>Efficacy &amp; Safety Quetiapine Fumarate ( SEROQUEL ) &amp; Placebo Treatment Acutely Ill Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Patient able provide write informed consent begin study related procedure Patient document clinical diagnosis schizophrenia Patient able understand comply requirement study , judge study investigator Patients history noncompliance judge study investigator Patients know lack response previous treatment quetiapine Patients participate another drug study within 4 week prior enrollment study Patients previously participate study study D1444C00132</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizophrenic disorder</keyword>
</DOC>